Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Fertil Steril ; 95(7): 2432.e17-9, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21513932

ABSTRACT

OBJECTIVE: To describe three clinical cases involving patients at high risk of severe ovarian hyperstimulation syndrome (OHSS) during IVF stimulation. DESIGN: Description of clinical management of IVF cycles and outcomes in patients at risk of developing OHSS. SETTING: Reproductive medicine unit, private hospital. PATIENT(S): Three infertile patients undergoing stimulation for IVF/intracytoplasmic sperm injection presenting high risk of OHSS. INTERVENTION(S): IVF patients treated under long protocol presenting high risk of OHSS had their cycles rescued by withdrawing the agonist and replacing it with an antagonist and triggering ovulation with an agonist bolus. MAIN OUTCOME MEASURE(S): OHSS symptoms, pregnancy. RESULT(S): None of the three patients developed OHSS. One patient got pregnant after fresh embryo transfer, one patient got pregnant after frozen embryo transfer, and one patient had no oocytes retrieved despite the detection of LH in urine after the GnRH bolus. CONCLUSION(S): When a patient undergoing an IVF cycle with long protocol is at high risk of severe OHSS, rescuing the cycle by withdrawing the agonist and replacing it with an antagonist and triggering ovulation with an agonist bolus could be considered without jeopardizing the safety of the patient while retaining the opportunity for success of the cycle. Further broader studies are needed.


Subject(s)
Fertility Agents, Female/administration & dosage , Fertilization in Vitro , Follicle Stimulating Hormone/administration & dosage , Gonadotropin-Releasing Hormone/agonists , Gonadotropin-Releasing Hormone/antagonists & inhibitors , Hormone Antagonists/administration & dosage , Ovarian Hyperstimulation Syndrome/prevention & control , Ovulation Induction/methods , Adult , Drug Administration Schedule , Embryo Transfer , Female , Fertility Agents, Female/adverse effects , Follicle Stimulating Hormone/adverse effects , Humans , Oocyte Retrieval , Ovarian Hyperstimulation Syndrome/chemically induced , Ovarian Hyperstimulation Syndrome/physiopathology , Ovulation/drug effects , Ovulation Induction/adverse effects , Pregnancy , Pregnancy Rate , Recombinant Proteins/administration & dosage , Risk Assessment , Risk Factors , Severity of Illness Index , Sperm Injections, Intracytoplasmic , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...